WebProf Jens-Uwe Blohmer, Charite - Universitätsmedizin Berlin (DE) Prof Arndt Büssing, Universität Witten/Herdecke (DE) Dr Francesco Cardini, Health & Social Regional Agency (ASSR) Emilia Romagna (IT) Dr Holger Cramer, Universität Duisburg-Essen, Kliniken Essen Mitte (DE) Dr Eduardo G. D Álessandro, São Paulo State Institute of Cancer (BR) WebApr 16, 2012 · Purpose The exact definition of pathologic complete response (pCR) and its prognostic impact on survival in intrinsic breast cancer subtypes is uncertain. Methods Tumor response at surgery and its association with long-term outcome of 6,377 patients with primary breast cancer receiving neoadjuvant anthracycline-taxane–based chemotherapy …
Differential effect on different immune subsets of neoadjuvant ...
WebJ.-U. Blohmer Endocrine therapy is the most effective targeted treatment option in the adjuvant setting for endocrine responsive breast cancer. In general, the duration of treatment with initial ... Web20 rows · Sep 7, 2024 · Vancouver. Blohmer, Jens-Uwe, David, Matthias, Henrich, … dvripc.cn
Prof. Dr. Jens-Uwe Blohmer: Charité Comprehensive …
WebSep 7, 2024 · Charité-Compendium Gynäkologie (German Edition) [Blohmer, Jens-Uwe / David, Matthias / Henrich, Wolfgang / Sehouli, Jalid] on Amazon.com. *FREE* shipping … WebFeb 15, 2024 · A Machleidt, N Schmidt-Feuerheerd, J-U Blohmer, R Ohlinger, J Küper, G von Waldenfels, S Dittmer, S Paepke, E Klein; Abstract P5-16-16: Reconstructive breast surgery with partially absorbable bi-component Seragyn® BR soft mesh: An outcome analysis. Cancer Res 15 February 2024; 79 (4_Supplement): P5–16–16. WebMiriam Ortiz, Institute of Social Medicine, Epidemiology, and Health Economics, Charité – Universitätsmedizin Berlin, Luisenstr. 57, Berlin 10117, Germany. Email: [email … reebok backpack lazada